Allotex

Zurich, Switzerland Founded: 2016 • Age: 10 yrs
Corneal allografts are developed for treating presbyopia and refractive errors.

About Allotex

Allotex is a company based in Zurich (Switzerland) founded in 2016 by Michael Mrochen and David Muller.. Allotex has raised $46.75 million across 3 funding rounds from investors including Exor, Junson Capital and KCK MedTech. Allotex operates in a competitive market with competitors including TECLens, Adaptilens, Visco Vision, Presbia and Shanghai Conant Optical, among others.

  • Headquarter Zurich, Switzerland
  • Founders Michael Mrochen, David Muller
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $46.75 M (USD)

    in 3 rounds

  • Latest Funding Round
  • Investors
    Exor

    & 4 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Allotex
Headcount 10-50
Employee Profiles 3
Employee Profiles
People
Evan Sherr
Chief Operating Officer
People
David Muller
President & CEO
People
Travis Henry
Office Manager At Allotex, Inc.

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Allotex

Allotex has successfully raised a total of $46.75M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round
  • First Round

    (22 Feb 2018)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2023 Amount Series B - Allotex Valuation Junson Capital
Jul, 2023 Amount Series B - Allotex Valuation KCK MedTech
Feb, 2018 Amount Series B - Allotex Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Allotex

Allotex has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Exor, Junson Capital and KCK MedTech. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Allotex

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Allotex

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Allotex Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Allotex

Allotex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TECLens, Adaptilens, Visco Vision, Presbia and Shanghai Conant Optical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Noninvasive vision correction treatments for low myopia are developed.
domain founded_year HQ Location
Developer of intraocular lens
domain founded_year HQ Location
Silicone hydrogel-based contact lenses are supplied for vision correction.
domain founded_year HQ Location
Presbyopia is addressed via the implanted Presbia Flexivue Microlens.
domain founded_year HQ Location
Optical products for ophthalmic use, including specialized lenses, are manufactured.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Frequently Asked Questions about Allotex

When was Allotex founded?

Allotex was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Where is Allotex located?

Allotex is headquartered in Zurich, Switzerland.

Who is the current CEO of Allotex?

Michael Mrochen is the current CEO of Allotex. They have also founded this company.

Is Allotex a funded company?

Allotex is a funded company, having raised a total of $46.75M across 3 funding rounds to date. The company's 1st funding round was a Series B of $16.75M, raised on Feb 22, 2018.

What does Allotex do?

Allotex was founded in 2016 in Zurich, Switzerland, within the ophthalmology sector. Therapeutic solutions are developed using tissue addition technology, where human corneal allografts are precisely shaped for use as contact lenses or inserts. These allografts are positioned on or just under Bowmans layer to address presbyopia, hyperopia, myopia, and astigmatism. Operations focus on customizable shapes, diameters, and thicknesses for the grafts.

Who are the top competitors of Allotex?

Allotex's top competitors include TECLens, Adaptilens and Shanghai Conant Optical.

Who are Allotex's investors?

Allotex has 5 investors. Key investors include Exor, Junson Capital, KCK MedTech, Panakes Partners, and Supernova Invest.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available